172 related articles for article (PubMed ID: 25353144)
1. A cartridge based sensor array platform for multiple coagulation measurements from plasma.
Cakmak O; Ermek E; Kilinc N; Bulut S; Baris I; Kavakli IH; Yaralioglu GG; Urey H
Lab Chip; 2015 Jan; 15(1):113-20. PubMed ID: 25353144
[TBL] [Abstract][Full Text] [Related]
2. Point-of-care testing of neonatal coagulation.
Tan K; Booth D; Newell SJ; Dear PR; Hughes C; Richards M
Clin Lab Haematol; 2006 Apr; 28(2):117-21. PubMed ID: 16630216
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the GEM®PCL Plus point-of-care device for neonatal coagulation assessment: an observational study on cord blood.
De Luca R; Fontana P; Poncet A; de Moerloose P; Pfister RE
Thromb Res; 2014 Aug; 134(2):474-8. PubMed ID: 24951336
[TBL] [Abstract][Full Text] [Related]
4. Evaluation and performance characteristics of the Q Hemostasis Analyzer, an automated coagulation analyzer.
Toulon P; Fischer F; Appert-Flory A; Jambou D
Thromb Res; 2014 May; 133(5):927-35. PubMed ID: 24650798
[TBL] [Abstract][Full Text] [Related]
5. Standardization of coagulation tests.
Opartkiattikul N
Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
[TBL] [Abstract][Full Text] [Related]
6. Microcantilever based disposable viscosity sensor for serum and blood plasma measurements.
Cakmak O; Elbuken C; Ermek E; Mostafazadeh A; Baris I; Erdem Alaca B; Kavakli IH; Urey H
Methods; 2013 Oct; 63(3):225-32. PubMed ID: 23880427
[TBL] [Abstract][Full Text] [Related]
7. Validation of the minimal citrate tube fill volume for routine coagulation tests on ACL TOP 500 CTS®.
Ver Elst K; Vermeiren S; Schouwers S; Callebaut V; Thomson W; Weekx S
Int J Lab Hematol; 2013 Dec; 35(6):614-9. PubMed ID: 23663653
[TBL] [Abstract][Full Text] [Related]
8. Comparability of the results of PT-INR with local MNPT and APTTR with MNAPTT on different coagulation analyzers in China.
Peng L; Yan C; Wu X; Nie L
Int J Lab Hematol; 2009 Jun; 31(3):352-8. PubMed ID: 18510575
[TBL] [Abstract][Full Text] [Related]
9. Coagulation measurement from whole blood using vibrating optical fiber in a disposable cartridge.
Yaraş YS; Gündüz AB; Sağlam G; Ölçer S; Civitçi F; Baris İ; Yaralioğlu G; Urey H
J Biomed Opt; 2017 Nov; 22(11):1-8. PubMed ID: 29127692
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a bench-top coagulation analyzer for measurement of prothrombin time, activated partial thromboplastin time, and fibrinogen concentrations in healthy dogs.
Mineo HK; Garabed RB
Am J Vet Res; 2007 Dec; 68(12):1342-7. PubMed ID: 18052739
[TBL] [Abstract][Full Text] [Related]
11. Impact of telavancin on prothrombin time and activated partial thromboplastin time as determined using point-of-care coagulometers.
Ero MP; Harvey NR; Harbert JL; Janc JW; Chin KH; Barriere SL
J Thromb Thrombolysis; 2014; 38(2):235-40. PubMed ID: 24132401
[TBL] [Abstract][Full Text] [Related]
12. [Prothrombin time and thromboplastin time. On-site measurement of the prothrombin time and activated partial thromboplastin time of surgical patients with laser photometry].
Tschaikowsky K; Balint R; Pscheidl E; Bremer F
Anaesthesist; 1998 Apr; 47(4):295-302. PubMed ID: 9615846
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative measurement of activated partial thromboplastin time and prothrombin time by a portable laser photometer in patients following cardiopulmonary bypass.
Nuttall GA; Oliver WC; Beynen FM; Dull JJ; Murray MJ; Nichols WL
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):402-9. PubMed ID: 8400094
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Q analyzer, a new cap-piercing fully automated coagulometer with clotting, chromogenic, and immunoturbidometric capability.
Kitchen S; Woolley A
Blood Coagul Fibrinolysis; 2013 Jan; 24(1):28-34. PubMed ID: 23249565
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin time.
Kitchen S; Geisen U; Kappelmayer J; Quehenberger P; Drieß J; Lowe A; Jones R; Boehm JG; Miles G; Rozsnyai G
Int J Lab Hematol; 2018 Dec; 40(6):645-654. PubMed ID: 30033570
[TBL] [Abstract][Full Text] [Related]
16. Fluorescence-based blood coagulation assay device for measuring activated partial thromboplastin time.
Dudek MM; Kent N; Gustafsson KM; Lindahl TL; Killard AJ
Anal Chem; 2011 Jan; 83(1):319-28. PubMed ID: 21121686
[TBL] [Abstract][Full Text] [Related]
17. Point-of-care PT and aPTT in patients with suspected deficiencies of coagulation factors.
Niederdöckl J; Dempfle CE; Schönherr HR; Bartsch A; Miles G; Laggner A; Pathil A
Int J Lab Hematol; 2016 Aug; 38(4):426-34. PubMed ID: 27384253
[TBL] [Abstract][Full Text] [Related]
18. QCM-D providing new horizon in the domain of sensitivity range and information for haemostasis of human plasma.
Hussain M; Northoff H; Gehring FK
Biosens Bioelectron; 2015 Apr; 66():579-84. PubMed ID: 25530537
[TBL] [Abstract][Full Text] [Related]
19. Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data.
Hirai N; Tatsumi N; Hino M; Yamane T; Ohta K
Osaka City Med J; 1998 Jun; 44(1):55-71. PubMed ID: 9834619
[TBL] [Abstract][Full Text] [Related]
20. Effects of telavancin on coagulation test results.
Barriere SL; Goldberg MR; Janc JW; Higgins DL; Macy PA; Adcock DM
Int J Clin Pract; 2011 Jul; 65(7):784-9. PubMed ID: 21564449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
